B. Warrack

发表

Understanding and Controlling Sialylation in a CHO Fc-Fusion Process

Nicholas R. Abu-Absi, Michael C. Borys, A. Lewis, 2016, PloS one.

Normalization strategies for metabonomic analysis of urine samples.

B. Warrack, M. Reily, K. Ott, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Addressing drug effects on cut point determination for an anti-drug antibody assay.

B. Warrack, Kelli R Phillips, Guodong Chen, 2012, Journal of immunological methods.

Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance

J. Hunt, B. Warrack, M. Reily, 2019, PloS one.

Observation of internal monosaccharide losses in the collisionally activated dissociation mass spectra of anthracycline aminodisaccharides

B. Warrack, R. Seraglia, M. Hail, 1998 .

Disposition of [1′-14C]Stavudine after Oral Administration to Humans

V. Roongta, B. Warrack, S. Kaul, 2010, Drug Metabolism and Disposition.

Determination of the molecular weight of poly(ethylene glycol) in biological samples by reversed-phase LC–MS with in-source fragmentation

B. Warrack, Guodong Chen, M. Bolgar, 2013, Analytical and Bioanalytical Chemistry.

Search for an endogenous mammalian cardiotonic factor.

K. Nakanishi, N. Berova, B. Warrack, 1996, Advances in experimental medicine and biology.

Design, Synthesis, and Structure-Activity Relationships of Novel Tetrahydroisoquinolino Benzodiazepine Dimer Antitumor Agents and Their Application in Antibody-Drug Conjugates.

A. Mathur, B. Warrack, A. Rajpal, 2020, Journal of medicinal chemistry.

Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P1) Modulator Advanced into Clinical Trials.

Michael G. Yang, K. McIntyre, D. Shen, 2019, Journal of medicinal chemistry.

A tris (2-carboxyethyl) phosphine (TCEP) related cleavage on cysteine-containing proteins

B. Warrack, Reb J. Russell, Wei Wu, 2010, Journal of the American Society for Mass Spectrometry.

Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).

Michael A. Galella, K. McIntyre, D. Shen, 2016, Journal of medicinal chemistry.

Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer.

A. Doweyko, G. Trainor, A. Fura, 2016, ACS medicinal chemistry letters.

Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P1 Receptor Modulator.

Michael G. Yang, K. McIntyre, D. Shen, 2016, Journal of medicinal chemistry.

ADMINISTRATION TO HUMANS

V. Roongta, B. Warrack, S. Kaul, 2010 .

Disposition of [1 (cid:1) - 14 C]Stavudine after Oral Administration to Humans

V. Roongta, B. Warrack, S. Kaul, 2010 .

Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.

B. Warrack, Guodong Chen, A. Tymiak, 2011, Drug discovery today.

New insights into genetic instability of an industrial CHO cell line by orthogonal omics

Michael C. Borys, N. Araníbar, B. Warrack, 2020 .

Bigdata analytics identifies metabolic inhibitors and promoters for productivity improvement and optimization of monoclonal antibody (mAb) production process

Caitlin S. Morris, Michael C. Borys, B. Warrack, 2020, Bioresources and Bioprocessing.

Prodrugs of BMS-183920: metabolism and permeability considerations.

S. Chong, A. Marino, R. Morrison, 1996, Journal of pharmaceutical sciences.

Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design.

K. McIntyre, D. Shuster, D. Shen, 2016, Journal of medicinal chemistry.

Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.

S. Spergel, R. Moquin, K. McIntyre, 2016, Journal of medicinal chemistry.

Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.

K. McIntyre, D. Shen, J. Barrish, 2016, ACS medicinal chemistry letters.

Determination of Real Time in Vivo Drug Receptor Occupancy for a Covalent Binding Drug as a Clinical Pharmacodynamic Biomarker by Immunocapture-LC-MS/MS.

Robert J. Neely, Yan J. Zhang, B. Warrack, 2019, Analytical chemistry.

14-3-3 Lambda Protein Affects Anthocyanin Production in Arabidopsis thaliana during Drought Stress

Serhiy Hnatyshyn, Kenneth Russell Myers, Bethanne M. Warrack, 2017 .

Ion spray liquid chromatographic/mass spectrometric characterization of bile acids.

B. Warrack, G. Didonato, 1993, Biological mass spectrometry.

Characterization of rabbit myocardial phospholipase A2 activity using endogenous phospholipid substrates.

B. Warrack, G. Grover, M. Ogletree, 1994, Analytical biochemistry.

Development of an on-line automated sample clean-up method and liquid chromatography–tandem mass spectrometry analysis: application in an in vitro proteolytic assay

B. Warrack, Joseph L. Cantone, D. Drexler, 2006, Analytical and bioanalytical chemistry.

Increased MSX level improves biological productivity and production stability in multiple recombinant GS CHO cell lines

Michael C. Borys, N. Araníbar, B. Warrack, 2020, Engineering in life sciences.

Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.

B. Warrack, Guodong Chen, A. Tymiak, 2011, Drug discovery today.

Utility of the hybrid LTQ-FTMS for drug metabolism applications.

B. Warrack, P. Shipkova, M. Sanders, 2006, Current drug metabolism.